You are here

  • Home
  • Archive
  • Volume 109, Issue 5
  • Response to: Correspondence on “Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study” by Marateb et al

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Response to: Correspondence on “Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study” by Marateb et al

http://dx.doi.org/10.1136/heartjnl-2022-322247

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @MarceloMartinsP, @tomribeiroecg

    • Contributors All authors contributed to further analysis and interpretation of the data, writing the response and reviewing the final text.

    • Funding The WHF COVID-19 Global Cardiovascular Disease Study is funded by WHF and unconditional research grant by Sanofi and Pfizer. The study was conducted independently without any direct involvement of the funders. The funding agencies were not involved in the study design, conduct, analysis or reporting of the results or manuscript preparation. ALPR s supported in part by CNPq (310790/2021-2 and 465518/2014-1), by FAPEMIG (PPM-00428-17 and RED-00081-16) and CAPES (88887.507149/2020-00).

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles